P

Inventor

LEFTHERIS KATERINA

US89 patents
⚠️ This page may combine multiple inventors who share the name “LEFTHERIS KATERINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

30 patents
US6399773B1Jun 4, 2002

Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme

BRISTOL MYERS SQUIBB CO105 citations98
US6838559B2Jan 4, 2005

Purine inhibitors of phosphodiesterase (PDE) 7

BRISTOL MYERS SQUIBB CO79 citations97
US6011029AJan 4, 2000

Inhibitors of farnesyl protein transferase

BRISTOL MYERS SQUIBB CO107 citations96
US6670357B2Dec 30, 2003

Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO137 citations95
US7473784B2Jan 6, 2009

Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO28 citations93
US6653304B2Nov 25, 2003

Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases

BRISTOL MYERS SQUIBB CO62 citations93
US7592338B2Sep 22, 2009

Pyrazole-amine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO9 citations92
US7414056B2Aug 19, 2008

Pyrazole-amide compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO12 citations92
US7396935B2Jul 8, 2008

Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO15 citations92
US7253170B2Aug 7, 2007

Pyrazole-amine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO10 citations92
US7160883B2Jan 9, 2007

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO23 citations92
US7151113B2Dec 19, 2006

Pyrazole-amine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO19 citations92
US6962915B2Nov 8, 2005

Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO27 citations92
US6602883B1Aug 5, 2003

Inhibitors of farnesyl protein transferase

BRISTOL MYERS SQUIBB CO23 citations92
US6458783B1Oct 1, 2002

Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase

BRISTOL MYERS SQUIBB CO29 citations92
US6387926B1May 14, 2002

Inhibitors of farnesyl protein transferase

BRISTOL MYERS SQUIBB CO38 citations92
US6156746ADec 5, 2000

1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents

BRISTOL MYERS SQUIBB CO36 citations92
US6455523B1Sep 24, 2002

Inhibitors of farnesyl protein transferase

BRISTOL MYERS SQUIBB CO17 citations91
US6867300B2Mar 15, 2005

Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO45 citations90
US7605273B2Oct 20, 2009

Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO8 citations84
US7390810B2Jun 24, 2008

Pyrazole-amine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO9 citations84
US7323482B2Jan 29, 2008

Thiazolyl-based compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO12 citations84
US7169771B2Jan 30, 2007

Thiazolyl-based compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations84
US6596747B2Jul 22, 2003

Compounds derived from an amine nucleus and pharmaceutical compositions comprising same

BRISTOL MYERS SQUIBB CO20 citations84
US7759343B2Jul 20, 2010

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations83
US7462616B2Dec 9, 2008

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO12 citations83
US7211666B2May 1, 2007

Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO12 citations82
US7034151B2Apr 25, 2006

Process for preparing pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO17 citations82
US7314876B2Jan 1, 2008

Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO7 citations74
US8044040B2Oct 25, 2011

N-heterocyclic inhibitors of TNF-alpha expression

BRISTOL MYERS SQUIBB CO6 citations73

CLAREMON DAVID A

5 patents

VITAE PHARMACEUTICALS INC

4 patents

PLIANT THERAPEUTICS INC

3 patents

PHARMACOPEIA INC

2 patents

SIGNAL PHARM LLC

2 patents

(unassigned)

1 patent

PHARMACEOPEIA INC

1 patent

LIU CHUNJIAN

1 patent

CACATIAN SALVACION

1 patent

Showing the top 50 of 89 patents by PatentIndex Score.